Today: 21 May 2026
Browse Category

NASDAQ:ASAN 4 January 2026 - 13 January 2026

Asana stock drops 7% today as software names slide after CPI — what to watch next

Asana stock drops 7% today as software names slide after CPI — what to watch next

Asana shares fell 7.1% to $12.04 Tuesday afternoon, underperforming major indexes after U.S. inflation data showed a 2.7% annual rise in December. The drop mirrored declines in other cloud software stocks. Company news was limited, though Asana launched a new automation feature late Monday. Investors are watching the Fed’s Jan. 27-28 meeting and Asana’s fiscal year-end on Jan. 31.
13 January 2026
····
Asana stock slides 5% to start 2026 — downgrade and key dates that could move ASAN next

Asana stock slides 5% to start 2026 — downgrade and key dates that could move ASAN next

Asana shares fell 5.4% to $12.96 Friday after Wall Street Zen downgraded the stock to “hold,” MarketBeat reported. The drop leaves Asana near its 52-week low, with investors watching for signs of further U.S. rate cuts after Fed officials signaled patience. The S&P 500 rose 0.2% while the Nasdaq-100 slipped 0.2%. Asana last forecast Q4 revenue of $204 million to $206 million.
4 January 2026
··

Stock Market Today

  • Sharda Cropchem Earnings Reveal Weak Cash Flow Despite Profit Growth
    May 20, 2026, 9:35 PM EDT. Sharda Cropchem Limited's (NSE:SHARDACROP) recent earnings report shows a statutory profit of ₹6.81 billion for the year ending March 2026, but free cash flow was significantly lower at ₹1.6 billion, resulting in a high accrual ratio of 0.23. This suggests the company's cash conversion is less than ideal, raising concerns about the sustainability of its earnings. Despite this, Sharda Cropchem's earnings per share (EPS) has grown impressively over the past three years. Investors remain cautious due to three warning signs surrounding the stock, with one marked as significant. The gap between profit and cash flow indicates that reported profits may overstate the company's underlying earning power.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop